Beck, L.A., Cork, M.J. orcid.org/0000-0003-4428-2428, Amagai, M. et al. (4 more authors) (2022) Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innovations, 2 (5). 100131. ISSN 2667-0267
Abstract
Skin barrier dysfunction, a defining feature of atopic dermatitis (AD), arises from multiple interacting systems. In AD, skin inflammation is caused by host–environment interactions involving keratinocytes, as well as tissue-resident immune cells such as type 2 innate lymphoid cells, basophils, mast cells, and T-helper type 2 cells, which produce type 2 cytokines including interleukin (IL)-4, IL-5, IL-13, and IL-31. Type 2 inflammation broadly impacts expression of genes relevant for barrier function, such as intracellular structural proteins, extracellular lipids, and junctional proteins, and enhances Staphylococcus aureus skin colonization. Systemic anti-type 2 inflammation therapies may improve dysfunctional skin barrier in AD.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
Keywords: | atopic dermatitis; interleukin 4; interleukin 13; skin barrier; stratum corneum; tight junction; type 2 inflammation |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Sheffield Teaching Hospitals |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 17 May 2022 13:30 |
Last Modified: | 30 Aug 2022 10:27 |
Status: | Published |
Publisher: | Elsevier |
Refereed: | Yes |
Identification Number: | 10.1016/j.xjidi.2022.100131 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:186902 |